ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Metastases
Interventions: DRUG: ANG1005
Sponsor: Angiochem Inc